Sophie Nixon

Dr. Sophie Nixon

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2019 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
SNSophie Nixon
Sophie Nixon
LRLindsay Rose
Lindsay Rose
AMAnnika T. Muller
Annika T. Muller
Background Acute diarrhea is a common clinical presentation of dogs. The effect of specific anti‐diarrheal probiotic pastes (ADPPs) in the management of acute, uncomplicated diarrhea in dogs is unknown. Hypothesis Administration of an ADPP containing Enterococcus faecium 4b1707 will improve the clinical outcome of acute, uncomplicated diarrhea in dogs compared to placebo. Animals One hundred forty‐eight client‐owned dogs with acute diarrhea as the main clinical sign. Methods Double‐blinded, placebo‐controlled, randomized, blocked, multicenter clinical field study conducted at 14 primary care veterinary practices in the United Kingdom and Ireland. Results The ADPP was associated with better clinical outcome compared to placebo in dogs with acute, uncomplicated diarrhea. Dogs in the ADPP group had a significantly shorter duration of diarrhea (ADPP: median, 32 hours; 95% confidence interval [CI], 2‐118; n = 51; Placebo: median, 47 hours; 95% CI, 4‐167; n = 58; P = .008) and the rate of resolution of diarrhea was 1.60 times faster in the ADPP group than in the Placebo group (ratio, 1.60; 95% CI, 1.08‐2.44; P = .02). Fewer dogs required additional medical intervention (AMI) for non‐improvement or worsening in the ADPP group compared to the Placebo group (3.5% of dogs and 14.8% of dogs, respectively), with a relative risk of 0.88 (P = .04; AMI, ADPP, 3.5%, 2/57 dogs; Placebo, 14.8%, 9/61 dogs; relative risk, 0.88; 95% CI, 0.77‐0.99). Conclusion and Clinical Importance The ADPP may accelerate resolution of acute diarrhea in dogs and decrease the requirement for AMI.

19 November 2019 in Nature Communications
Verified
Journal Article
Open access
TETommas J. Ellender
Tommas J. Ellender
SASophie V. Avery
Sophie V. Avery
KMKashif Mahfooz
Kashif Mahfooz
JSJakub Scaber
Jakub Scaber
AKAlexander von Klemperer
Alexander von Klemperer
CAColin J. Akerman
Colin J. Akerman
The mammalian neocortex is characterized by a variety of neuronal cell types and precise arrangements of synaptic connections, but the processes that generate this diversity are poorly understood. Here we examine how a pool of embryonic progenitor cells consisting of apical intermediate progenitors (aIPs) contribute to diversity within the upper layers of mouse cortex. In utero labeling combined with single-cell RNA-sequencing reveals that aIPs can generate transcriptionally defined glutamatergic cell types, when compared to neighboring neurons born from other embryonic progenitor pools. Whilst sharing layer-associated morphological and functional properties, simultaneous patch clamp recordings and optogenetic studies reveal that aIP-derived neurons exhibit systematic biases in both their intralaminar monosynaptic connectivity and the post-synaptic partners that they target within deeper layers of cortex. Multiple cortical progenitor pools therefore represent an important factor in establishing diversity amongst local and long-range fine-scale glutamatergic connectivity, which generates subnetworks for routing excitatory synaptic information.

3 January 2024 in Journal of Animal Science
Verified
Journal Article
Closed access
PDF file
EKEmanuela Kayser
Emanuela Kayser
FHFei He
Fei He
SNSophie Nixon
Sophie Nixon
AHAdrian Howard-Varona
Adrian Howard-Varona
ALAraceli Lamelas
Araceli Lamelas
MGMaria Cattai De Godoy
Maria Cattai De Godoy
The popularity of functional ingredients such as probiotics and postbiotics has increased as pet owners seek ways to improve the health quality and longevity of their pets. Limited research has been conducted regarding the use of probiotics and postbiotics and their effects on canine health. The objective of this study was to evaluate the effects of daily supplementation of Bifidobacterium animalis subsp. lactis CECT 8145, in both live probiotic (PRO) and heat-treated postbiotic (POST) forms, on fecal fermentative end-products and microbiome, insulin sensitivity, serum gut hormones, oxidative stress, inflammatory biomarkers, and white blood cell gene expression of adult dogs. Eighteen adult beagles and 18 adult English pointers were used in a double-blinded placebo controlled parallel group design, with 12 animals per group (6 English pointers and 6 beagles). The study began with a 60 d adaptation period followed by a 90 d period of daily supplementation with either PRO, POST, or placebo (maltodextrin; CON). Longitudinal assessment of body weight (BW), body condition score (BCS), and pelvic circumference (PC) did not differ among dietary supplements (P > 0.05). Throughout the experimental period, fecal scores did not differ (P > 0.05), however, fecal pH was lower (P = 0.0049) in the dogs fed POST compared with CON. A higher fecal concentration of propionate (P = 0.043) was observed in dogs fed PRO and POST when compared with CON. While PRO and POST supplementation was associated with changes in bacterial composition at the family and genus level, the overall richness and diversity of the microbiome was not significantly affected. Functional analysis of the metagenome also suggests that PRO and POST supplementation induced potentially beneficial changes in the abundance of pathways involved in pathogenicity, amino acid biosynthesis and DNA repair. No differences in glycemic or insulinemic responses were observed among the groups (P > 0.05). Dogs supplemented with PRO had a higher (P < 0.05) mean white blood cell leptin relative fold gene expression compared with groups POST and CON. Serum metabolites and complete blood cells counts were within normal ranges and all dogs remained healthy throughout the study. Together, these data suggest that the PRO and POST can safely be supplemented for dogs. Moreover, the results of this study support further investigation of the role of PRO and POST in supporting parameters related to gut health and hormonal regulation.

30 May 2025 in Animals
Verified
Journal Article
Open access
PDF file
AFAdrián Florit-Ruiz
Adrián Florit-Ruiz
LRLaura Rago
Laura Rago
ARAntonia Rojas
Antonia Rojas
BGBellahanum Guzelkhanova
Bellahanum Guzelkhanova
APAdria Pont-Beltran
Adria Pont-Beltran
SNSophie Nixon
Sophie Nixon
Periodontal diseases are highly prevalent in dogs and intricately interconnected with the composition and functional attributes of the oral microbiota. The demand for non-invasive interventions to support oral health presents an opportunity for functional ingredients. The novel postbiotic heat-treated (HT) Lactiplantibacillus plantarum CECT 9161 inhibited growth and biofilm formation of oral microorganisms in vitro. The in vitro growth of saliva-derived biofilms was also inhibited and revealed microbiome modulation. Two doses of the postbiotic (LOW: 5 mg dog/day, HIGH: 25 mg/dog/day) were assessed in a placebo-controlled, double-blinded, 57-day clinical trial involving 60 dogs. Associations were found between the postbiotic, reduced plaque formation, and modulation of the oral microbiome, including increased abundance of genes involved in denitrification, heme and catechol biosynthesis, and oxidative stress reduction. The results suggest that HT Lactiplantibacillus plantarum CECT 9161 may support oral health in dogs by modifying the microbiome of supragingival plaque and reducing plaque formation.

15 January 2026 in Animals
Verified
Journal Article
Open access
PDF file
Sarah Michelle DickersonSarah Michelle Dickerson
Sarah Michelle Dickerson
CTClaire Timlin
Claire Timlin
FMFiona B Mccracken
Fiona B Mccracken
PSPatrick Skaggs
Patrick Skaggs
SNSophie Nixon
Sophie Nixon
CCCraig Nelson Coon
Craig Nelson Coon
This study explored the effects of Bifidobacterium animalis subspecies lactis CECT 8145 (B. animalis CECT 8145)—in both live probiotic and heat-treated postbiotic form—on metabolic health and digestion in male and female Labrador Retrievers during weight gain and loss. The study consisted of two, seven-week phases: weight gain (200% maintenance energy intake; Phase (1) and weight loss (100% maintenance energy requirement for ideal weight; Phase (2), separated by a 2-week washout period. In each phase, forty-five adult Labrador Retrievers (1.6–12.5 years) were randomly assigned to daily supplementation with live B. animalis CECT 8145 probiotic (PRO, n = 15), heat-treated B. animalis CECT 8145 postbiotic (POST, n = 15), or placebo control (CON, n = 15). Body weight, body condition score, fecal quality and food consumption were monitored throughout the study, and body composition, fecal, and blood samples were analyzed at the beginning and end of each phase. Digestibility was evaluated at the end of each phase. Post-prandial glucose responses were affected by intervention during weight loss, with a 6% reduction in the area under the curve (AUC) in POST compared to CON dogs (p = 0.035). Glucagon was decreased in females supplemented with POST (p = 0.0014), while POST males showed increased glucagon-like peptide-1 (GLP-1) compared to CON (p = 0.016) during weight gain. Serum GGT levels decreased, within the normal reference range, in POST compared to CON dogs during weight gain (post hoc p = 0.041). Fecal isovalerate was also reduced and fat digestibility increased (p = 0.026) in POST compared to CON (p = 0.018) during weight gain. There was a significant association between the group and gastric inhibitory polypeptide (GIP), with a decrease in GIP in POST over time (p = 0.030), and glucagon tended to be decreased in POST compared to CON (p = 0.073). Overall, these findings suggest supplementation with postbiotic B. animalis CECT 8145 may improve certain markers of Labrador retrievers’ metabolic health.